NEW YORK (GenomeWeb) – Cancer genetics testing firm NeoGenomics today announced Aurora Diagnostics has selected it to be the primary partner for molecular testing in Aurora's US network of specialized pathology laboratories.

Aurora will be able to standardize oncology molecular testing services across its 19 labs as a result of the deal, NeoGenomics said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: human cytomegalovirus diversity, patterns of homologous recombination in E. coli, and more.

US lawmakers are considering eliminating the medical devices tax that is part of the Affordable Care Act.

Two research teams in China home in on a gene that gives rice a long, slender shape.

Marcia McNutt, the editor-in-chief of Science, has been nominated to become president of the US National Academy of Sciences.

Jul
14
Sponsored by
Agilent Technologies

This online seminar will outline a recent example of the use of molecular barcoding in combination with next-generation sequencing to detect somatic mosaicism in cancer patients.